Bottom line
What is EMOCX's expense ratio?
EMOCX's expense ratio is 1.67%, or about $167 a year on every $10,000 invested. That is more expensive than 98% of municipal bond funds we track (median 0.63%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Nov 25, 2025
EMOCX fee table
| Net expense ratio | 1.67% |
|---|---|
| Gross expense ratio | 1.72% |
| Management fee | 0.59% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.13% |
| Fee waiver / reimbursement | -0.05% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Nov 25, 2025
What EMOCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EMOCX | $270 | $537 | $929 | $1,827 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.67% expense ratio costs roughly $87,300 in lost growth, versus about $36,000 for the median municipal bond fund (0.63%).